Eintrag weiter verarbeiten
PIN44 COST-EFFECTIVENESS ANALYSIS OF 1 YEAR PEGINTERFERON ALFA-2A VERSUS 4 YEARS ENTECAVIR FOR THE TREATMENT OF HBEAG-POSITIVE CHRONIC HEPATITIS B IN CHINA
Gespeichert in:
| Zeitschriftentitel: | Value in Health |
|---|---|
| Personen und Körperschaften: | |
| In: | Value in Health, 13, 2010, 7, S. A438 |
| Format: | E-Article |
| Sprache: | Englisch |
| veröffentlicht: |
Elsevier BV
|
| Schlagwörter: |
| author_facet |
Chen, W Chen, W |
|---|---|
| author |
Chen, W |
| spellingShingle |
Chen, W Value in Health PIN44 COST-EFFECTIVENESS ANALYSIS OF 1 YEAR PEGINTERFERON ALFA-2A VERSUS 4 YEARS ENTECAVIR FOR THE TREATMENT OF HBEAG-POSITIVE CHRONIC HEPATITIS B IN CHINA Public Health, Environmental and Occupational Health Health Policy |
| author_sort |
chen, w |
| spelling |
Chen, W 1098-3015 Elsevier BV Public Health, Environmental and Occupational Health Health Policy http://dx.doi.org/10.1016/s1098-3015(11)72842-x PIN44 COST-EFFECTIVENESS ANALYSIS OF 1 YEAR PEGINTERFERON ALFA-2A VERSUS 4 YEARS ENTECAVIR FOR THE TREATMENT OF HBEAG-POSITIVE CHRONIC HEPATITIS B IN CHINA Value in Health |
| doi_str_mv |
10.1016/s1098-3015(11)72842-x |
| facet_avail |
Online Free |
| finc_class_facet |
Medizin |
| format |
ElectronicArticle |
| fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAxNi9zMTA5OC0zMDE1KDExKTcyODQyLXg |
| id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAxNi9zMTA5OC0zMDE1KDExKTcyODQyLXg |
| institution |
DE-Gla1 DE-Zi4 DE-15 DE-Pl11 DE-Rs1 DE-105 DE-14 DE-Ch1 DE-L229 DE-D275 DE-Bn3 DE-Brt1 DE-D161 DE-Zwi2 |
| imprint |
Elsevier BV, 2010 |
| imprint_str_mv |
Elsevier BV, 2010 |
| issn |
1098-3015 |
| issn_str_mv |
1098-3015 |
| language |
English |
| mega_collection |
Elsevier BV (CrossRef) |
| match_str |
chen2010pin44costeffectivenessanalysisof1yearpeginterferonalfa2aversus4yearsentecavirforthetreatmentofhbeagpositivechronichepatitisbinchina |
| publishDateSort |
2010 |
| publisher |
Elsevier BV |
| recordtype |
ai |
| record_format |
ai |
| series |
Value in Health |
| source_id |
49 |
| title |
PIN44 COST-EFFECTIVENESS ANALYSIS OF 1 YEAR PEGINTERFERON ALFA-2A VERSUS 4 YEARS ENTECAVIR FOR THE TREATMENT OF HBEAG-POSITIVE CHRONIC HEPATITIS B IN CHINA |
| title_unstemmed |
PIN44 COST-EFFECTIVENESS ANALYSIS OF 1 YEAR PEGINTERFERON ALFA-2A VERSUS 4 YEARS ENTECAVIR FOR THE TREATMENT OF HBEAG-POSITIVE CHRONIC HEPATITIS B IN CHINA |
| title_full |
PIN44 COST-EFFECTIVENESS ANALYSIS OF 1 YEAR PEGINTERFERON ALFA-2A VERSUS 4 YEARS ENTECAVIR FOR THE TREATMENT OF HBEAG-POSITIVE CHRONIC HEPATITIS B IN CHINA |
| title_fullStr |
PIN44 COST-EFFECTIVENESS ANALYSIS OF 1 YEAR PEGINTERFERON ALFA-2A VERSUS 4 YEARS ENTECAVIR FOR THE TREATMENT OF HBEAG-POSITIVE CHRONIC HEPATITIS B IN CHINA |
| title_full_unstemmed |
PIN44 COST-EFFECTIVENESS ANALYSIS OF 1 YEAR PEGINTERFERON ALFA-2A VERSUS 4 YEARS ENTECAVIR FOR THE TREATMENT OF HBEAG-POSITIVE CHRONIC HEPATITIS B IN CHINA |
| title_short |
PIN44 COST-EFFECTIVENESS ANALYSIS OF 1 YEAR PEGINTERFERON ALFA-2A VERSUS 4 YEARS ENTECAVIR FOR THE TREATMENT OF HBEAG-POSITIVE CHRONIC HEPATITIS B IN CHINA |
| title_sort |
pin44 cost-effectiveness analysis of 1 year peginterferon alfa-2a versus 4 years entecavir for the treatment of hbeag-positive chronic hepatitis b in china |
| topic |
Public Health, Environmental and Occupational Health Health Policy |
| url |
http://dx.doi.org/10.1016/s1098-3015(11)72842-x |
| publishDate |
2010 |
| physical |
A438 |
| description |
|
| container_issue |
7 |
| container_start_page |
0 |
| container_title |
Value in Health |
| container_volume |
13 |
| format_de105 |
Article, E-Article |
| format_de14 |
Article, E-Article |
| format_de15 |
Article, E-Article |
| format_de520 |
Article, E-Article |
| format_de540 |
Article, E-Article |
| format_dech1 |
Article, E-Article |
| format_ded117 |
Article, E-Article |
| format_degla1 |
E-Article |
| format_del152 |
Buch |
| format_del189 |
Article, E-Article |
| format_dezi4 |
Article |
| format_dezwi2 |
Article, E-Article |
| format_finc |
Article, E-Article |
| format_nrw |
Article, E-Article |
| _version_ |
1792322054225133568 |
| geogr_code |
not assigned |
| last_indexed |
2024-03-01T11:11:46.151Z |
| geogr_code_person |
not assigned |
| openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=PIN44+COST-EFFECTIVENESS+ANALYSIS+OF+1+YEAR+PEGINTERFERON+ALFA-2A+VERSUS+4+YEARS+ENTECAVIR+FOR+THE+TREATMENT+OF+HBEAG-POSITIVE+CHRONIC+HEPATITIS+B+IN+CHINA&rft.date=2010-11-01&genre=article&issn=1098-3015&volume=13&issue=7&pages=A438&jtitle=Value+in+Health&atitle=PIN44+COST-EFFECTIVENESS+ANALYSIS+OF+1+YEAR+PEGINTERFERON+ALFA-2A+VERSUS+4+YEARS+ENTECAVIR+FOR+THE+TREATMENT+OF+HBEAG-POSITIVE+CHRONIC+HEPATITIS+B+IN+CHINA&aulast=Chen&aufirst=W&rft_id=info%3Adoi%2F10.1016%2Fs1098-3015%2811%2972842-x&rft.language%5B0%5D=eng |
| SOLR | |
| _version_ | 1792322054225133568 |
| author | Chen, W |
| author_facet | Chen, W, Chen, W |
| author_sort | chen, w |
| container_issue | 7 |
| container_start_page | 0 |
| container_title | Value in Health |
| container_volume | 13 |
| description | |
| doi_str_mv | 10.1016/s1098-3015(11)72842-x |
| facet_avail | Online, Free |
| finc_class_facet | Medizin |
| format | ElectronicArticle |
| format_de105 | Article, E-Article |
| format_de14 | Article, E-Article |
| format_de15 | Article, E-Article |
| format_de520 | Article, E-Article |
| format_de540 | Article, E-Article |
| format_dech1 | Article, E-Article |
| format_ded117 | Article, E-Article |
| format_degla1 | E-Article |
| format_del152 | Buch |
| format_del189 | Article, E-Article |
| format_dezi4 | Article |
| format_dezwi2 | Article, E-Article |
| format_finc | Article, E-Article |
| format_nrw | Article, E-Article |
| geogr_code | not assigned |
| geogr_code_person | not assigned |
| id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAxNi9zMTA5OC0zMDE1KDExKTcyODQyLXg |
| imprint | Elsevier BV, 2010 |
| imprint_str_mv | Elsevier BV, 2010 |
| institution | DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-D161, DE-Zwi2 |
| issn | 1098-3015 |
| issn_str_mv | 1098-3015 |
| language | English |
| last_indexed | 2024-03-01T11:11:46.151Z |
| match_str | chen2010pin44costeffectivenessanalysisof1yearpeginterferonalfa2aversus4yearsentecavirforthetreatmentofhbeagpositivechronichepatitisbinchina |
| mega_collection | Elsevier BV (CrossRef) |
| physical | A438 |
| publishDate | 2010 |
| publishDateSort | 2010 |
| publisher | Elsevier BV |
| record_format | ai |
| recordtype | ai |
| series | Value in Health |
| source_id | 49 |
| spelling | Chen, W 1098-3015 Elsevier BV Public Health, Environmental and Occupational Health Health Policy http://dx.doi.org/10.1016/s1098-3015(11)72842-x PIN44 COST-EFFECTIVENESS ANALYSIS OF 1 YEAR PEGINTERFERON ALFA-2A VERSUS 4 YEARS ENTECAVIR FOR THE TREATMENT OF HBEAG-POSITIVE CHRONIC HEPATITIS B IN CHINA Value in Health |
| spellingShingle | Chen, W, Value in Health, PIN44 COST-EFFECTIVENESS ANALYSIS OF 1 YEAR PEGINTERFERON ALFA-2A VERSUS 4 YEARS ENTECAVIR FOR THE TREATMENT OF HBEAG-POSITIVE CHRONIC HEPATITIS B IN CHINA, Public Health, Environmental and Occupational Health, Health Policy |
| title | PIN44 COST-EFFECTIVENESS ANALYSIS OF 1 YEAR PEGINTERFERON ALFA-2A VERSUS 4 YEARS ENTECAVIR FOR THE TREATMENT OF HBEAG-POSITIVE CHRONIC HEPATITIS B IN CHINA |
| title_full | PIN44 COST-EFFECTIVENESS ANALYSIS OF 1 YEAR PEGINTERFERON ALFA-2A VERSUS 4 YEARS ENTECAVIR FOR THE TREATMENT OF HBEAG-POSITIVE CHRONIC HEPATITIS B IN CHINA |
| title_fullStr | PIN44 COST-EFFECTIVENESS ANALYSIS OF 1 YEAR PEGINTERFERON ALFA-2A VERSUS 4 YEARS ENTECAVIR FOR THE TREATMENT OF HBEAG-POSITIVE CHRONIC HEPATITIS B IN CHINA |
| title_full_unstemmed | PIN44 COST-EFFECTIVENESS ANALYSIS OF 1 YEAR PEGINTERFERON ALFA-2A VERSUS 4 YEARS ENTECAVIR FOR THE TREATMENT OF HBEAG-POSITIVE CHRONIC HEPATITIS B IN CHINA |
| title_short | PIN44 COST-EFFECTIVENESS ANALYSIS OF 1 YEAR PEGINTERFERON ALFA-2A VERSUS 4 YEARS ENTECAVIR FOR THE TREATMENT OF HBEAG-POSITIVE CHRONIC HEPATITIS B IN CHINA |
| title_sort | pin44 cost-effectiveness analysis of 1 year peginterferon alfa-2a versus 4 years entecavir for the treatment of hbeag-positive chronic hepatitis b in china |
| title_unstemmed | PIN44 COST-EFFECTIVENESS ANALYSIS OF 1 YEAR PEGINTERFERON ALFA-2A VERSUS 4 YEARS ENTECAVIR FOR THE TREATMENT OF HBEAG-POSITIVE CHRONIC HEPATITIS B IN CHINA |
| topic | Public Health, Environmental and Occupational Health, Health Policy |
| url | http://dx.doi.org/10.1016/s1098-3015(11)72842-x |